Patrik Johansson

Title: The Innovative Contributions of Patrik Johansson

Introduction

Patrik Johansson is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE inhibitors. His work is crucial in addressing various cognitive impairments and related pathologies.

Latest Patents

Johansson holds a patent for "Compounds and their use as BACE inhibitors." This patent relates to compounds of formula (I), (Ia), or (Ib) and their pharmaceutical compositions or preparations. The application focuses on methods for treating or preventing Aβ-related pathologies, including Down's syndrome, β-amyloid angiopathy, and disorders associated with cognitive impairment such as Alzheimer's disease and mild cognitive impairment.

Career Highlights

Patrik Johansson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the healthcare sector. With a patent portfolio that includes 1 patent, Johansson's research is paving the way for advancements in treating neurodegenerative diseases.

Collaborations

Johansson has collaborated with esteemed colleagues such as Roland W Bürli and Mark E Duggan. These partnerships have enhanced the research and development efforts in the pharmaceutical domain, leading to impactful innovations.

Conclusion

Patrik Johansson's contributions to the field of pharmaceuticals, particularly through his patent on BACE inhibitors, highlight his role as an influential inventor. His work continues to inspire advancements in the treatment of cognitive impairments and related disorders.